The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left.

作者信息

Maron Bradley A

机构信息

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA Department of Cardiology, Boston VA Healthcare System, Boston, Massachusetts, USA.

出版信息

Heart. 2016 Mar;102(5):335-6. doi: 10.1136/heartjnl-2015-309070.

DOI:10.1136/heartjnl-2015-309070

PMID:26869633

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4758692/

Abstract

摘要

相似文献

The quest for biomarker discovery in pulmonary arterial hypertension: the right takes lessons from the left.

Heart. 2016 Mar;102(5):335-6. doi: 10.1136/heartjnl-2015-309070.

Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.半乳糖凝集素-3通过与NADPH氧化酶4相互作用介导肺动脉高压诱导的右心室重塑。

J Am Soc Hypertens. 2017 May;11(5):275-289.e2. doi: 10.1016/j.jash.2017.03.008. Epub 2017 Mar 27.

NATURE OF CORRELATIONS AND DEPENDENCE OF PLASMA CONCENTRATIONS OF GALECTIN-3 AND ALDOSTERONE ON DIFFERENT CLINICAL CHARACTERISTICS IN MALE AND FEMALE PATIENTS WITH ARTERIAL HYPERTENSION.

Georgian Med News. 2019 Dec(297):74-79.

[Role of the angiotensin-aldosterone mechanism in the formation of Pulmonogenic arterial hypertension].[血管紧张素 - 醛固酮机制在肺源性动脉高血压形成中的作用]

Klin Med (Mosk). 1982 Jan;60(1):62-5.

Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.血清半乳糖凝集素-3 水平：与系统性硬皮病患者纤维化、异常血管生成和免疫激活的可能相关性。

J Rheumatol. 2012 Mar;39(3):539-44. doi: 10.3899/jrheum.110755. Epub 2012 Jan 15.

Atrial natriuretic factor in high-altitude pulmonary hypertension: the influence of acute hypoxia on plasma atrial natriuretic factor, renin, and aldosterone concentrations in highlanders with initially normal or elevated pulmonary artery pressure and without evidence of right ventricular hypertrophy.高原肺动脉高压中的心房利钠因子：急性缺氧对初始肺动脉压正常或升高且无右心室肥厚证据的高原居民血浆心房利钠因子、肾素和醛固酮浓度的影响。

Angiology. 1995 Sep;46(9):833-7. doi: 10.1177/000331979504600910.

Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.儿童肺动脉高压的基因检测与血液生物标志物。儿童肺动脉高压诊断与治疗专家共识声明。欧洲儿科肺血管疾病网络，由国际心脏和肺移植学会（ISHLT）及德国心肺协会（DGPK）认可。

Heart. 2016 May;102 Suppl 2:ii36-41. doi: 10.1136/heartjnl-2014-307238.

Atrial natriuretic peptide concentrations in children with pulmonary hypertension: correlation with hemodynamic measurements.

Pediatr Cardiol. 1994 Nov-Dec;15(6):288-95. doi: 10.1007/BF00798122.

Pulmonary hypertension. Response of vasoactive peptides to a nonionic contrast medium in patients undergoing pulmonary angiography.

Invest Radiol. 1995 Sep;30(9):511-6.

Atrial septostomy decreases sympathetic overactivity in pulmonary arterial hypertension.房间隔造口术可降低肺动脉高压患者的交感神经过度活动。

Chest. 2007 Jun;131(6):1831-7. doi: 10.1378/chest.06-2903. Epub 2007 Mar 30.

本文引用的文献

Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.半乳糖凝集素-3和醛固酮作为肺动脉高压潜在的串联生物标志物

Heart. 2016 Mar;102(5):390-6. doi: 10.1136/heartjnl-2015-308365.

Prognostic Significance of Biomarkers in Pulmonary Arterial Hypertension.生物标志物在肺动脉高压中的预后意义

Ann Am Thorac Soc. 2016 Jan;13(1):25-30. doi: 10.1513/AnnalsATS.201508-543OC.

Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH.心力衰竭的生物标志物和低风险。COACH 和 TRIUMPH 研究的数据。

Eur J Heart Fail. 2015 Dec;17(12):1271-82. doi: 10.1002/ejhf.407. Epub 2015 Oct 14.

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.安立生坦和他达拉非初始联合治疗硬皮病相关肺动脉高压

Am J Respir Crit Care Med. 2015 Nov 1;192(9):1102-10. doi: 10.1164/rccm.201507-1398OC.

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.初始使用安贝生坦联合他达拉非治疗肺动脉高压。

N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687.

Five-Year outcomes of patients enrolled in the REVEAL Registry.REVEAL 注册研究中入组患者的 5 年结局。

Chest. 2015 Oct;148(4):1043-54. doi: 10.1378/chest.15-0300.

Treatment goals of pulmonary hypertension.肺动脉高压的治疗目标。

J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D73-81. doi: 10.1016/j.jacc.2013.10.034.

A call to apply the minimal important difference in pulmonary arterial hypertension beyond the flawed 6-minute-walk test.呼吁在肺动脉高压中应用最小重要差异，而非存在缺陷的6分钟步行试验。

Am J Respir Crit Care Med. 2013 Mar 15;187(6):659. doi: 10.1164/ajrccm.187.6.659.

Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.在没有左心室心力衰竭的情况下，肺动脉高压患者的血浆醛固酮水平升高：一项初步研究。

Eur J Heart Fail. 2013 Mar;15(3):277-83. doi: 10.1093/eurjhf/hfs173. Epub 2012 Oct 30.

Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension.醛固酮通过半胱氨酸硫醇氧化还原开关使内皮素-B 受体失活，从而降低肺内皮细胞一氧化氮水平并调节肺动脉高压。

Circulation. 2012 Aug 21;126(8):963-74. doi: 10.1161/CIRCULATIONAHA.112.094722. Epub 2012 Jul 11.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验